50 employees
Gentis develops biomaterials-based products for the treatment of early-stage degeneration of the spine.
2000
$10M
from 4 investors over 4 rounds
Gentis Inc. raised $10M on June 21, 2007
Investors: MAT INVEST, Ivy Capital, Easton Capital Investment Group and Pappas Ventures